BACKGROUND: For rectal cancer patients who have already survived a period of time after diagnosis, survival probability changes and is more accurately depicted by conditional survival. The specific aim of this study was to develop an interactive tool for individualized estimation of changing prognosis for rectal cancer patients. METHODS: A multivariate Cox proportional hazards (CPH) survival model was constructed using data from rectal cancer patients diagnosed from 1994 to 2003 from the Surveillance, Epidemiology, and End Results (SEER) database. Age, race, sex, and stage were used as covariates in the survival prediction model. The primary outcome variable was overall survival conditional on having survived up to 5 years from diagnosis. RESULTS: Data from 42,830 rectal cancer patients met the inclusion criteria. The multivariate CPH model showed age, race, sex, and stage as significant independent predictors of survival. The survival prediction model demonstrated good calibration and discrimination, with a bootstrap-corrected concordance index of 0.75. A web-based prediction tool was built from this regression model that can compute individualized estimates of changing prognosis over time. CONCLUSIONS: An interactive prediction modeling tool can estimate prognosis for rectal cancer patients who have already survived a period of time after diagnosis and treatment. Having more accurate prognostic information can empower both patients and clinicians to be able to make more appropriate decisions regarding follow-up, surveillance testing, and future treatment.
BACKGROUND: For rectal cancerpatients who have already survived a period of time after diagnosis, survival probability changes and is more accurately depicted by conditional survival. The specific aim of this study was to develop an interactive tool for individualized estimation of changing prognosis for rectal cancerpatients. METHODS: A multivariate Cox proportional hazards (CPH) survival model was constructed using data from rectal cancerpatients diagnosed from 1994 to 2003 from the Surveillance, Epidemiology, and End Results (SEER) database. Age, race, sex, and stage were used as covariates in the survival prediction model. The primary outcome variable was overall survival conditional on having survived up to 5 years from diagnosis. RESULTS: Data from 42,830 rectal cancerpatients met the inclusion criteria. The multivariate CPH model showed age, race, sex, and stage as significant independent predictors of survival. The survival prediction model demonstrated good calibration and discrimination, with a bootstrap-corrected concordance index of 0.75. A web-based prediction tool was built from this regression model that can compute individualized estimates of changing prognosis over time. CONCLUSIONS: An interactive prediction modeling tool can estimate prognosis for rectal cancerpatients who have already survived a period of time after diagnosis and treatment. Having more accurate prognostic information can empower both patients and clinicians to be able to make more appropriate decisions regarding follow-up, surveillance testing, and future treatment.
Authors: Samuel J Wang; Rachel Emery; Clifton D Fuller; Jong-Sung Kim; Dean F Sittig; Charles R Thomas Journal: Gastric Cancer Date: 2007-09-26 Impact factor: 7.370
Authors: Tawnya L Bowles; Yan Xing; Chung-Yuan Hu; Kristi S Mungovan; Robert L Askew; George J Chang; Jeffrey E Gershenwald; Jeffrey E Lee; Paul F Mansfield; Merrick I Ross; Janice N Cormier Journal: Ann Surg Oncol Date: 2010-04-06 Impact factor: 5.344
Authors: Maryska L G Janssen-Heijnen; Adam Gondos; Freddie Bray; Timo Hakulinen; David H Brewster; Hermann Brenner; Jan-Willem W Coebergh Journal: J Clin Oncol Date: 2010-04-20 Impact factor: 44.544
Authors: Beth A Zamboni; Greg Yothers; Mehee Choi; Clifton D Fuller; James J Dignam; Peter C Raich; Charles R Thomas; Michael J O'Connell; Norman Wolmark; Samuel J Wang Journal: J Clin Oncol Date: 2010-04-20 Impact factor: 44.544
Authors: M L G Janssen-Heijnen; S Houterman; V E P P Lemmens; H Brenner; E W Steyerberg; J W W Coebergh Journal: Ann Oncol Date: 2007-08 Impact factor: 32.976
Authors: George J Chang; Chung-Yuan Hu; Cathy Eng; John M Skibber; Miguel A Rodriguez-Bigas Journal: J Clin Oncol Date: 2009-10-05 Impact factor: 44.544
Authors: Alyson L Mahar; Carolyn Compton; Susan Halabi; Kenneth R Hess; Martin R Weiser; Patti A Groome Journal: J Surg Oncol Date: 2017-08-02 Impact factor: 3.454
Authors: Marcus C B Tan; Jean M Butte; Mithat Gonen; Nancy Kemeny; Yuman Fong; Peter J Allen; T Peter Kingham; Ronald P Dematteo; William R Jarnagin; Michael I D'Angelica Journal: HPB (Oxford) Date: 2013-06-19 Impact factor: 3.647